Boehringer's Ofev Faces Efficacy Hurdle For SSc-ILD Indication At US FDA Advisory Cmte.

 
• By Michael Cipriano
lung illustration
Boehringer is eyeing another rare lung disease indication for Ofev's label.

More from US FDA Performance Tracker

More from Regulatory Trackers